Lucid Group Inc
Sentinellis Health Score
2.9/10
$2.2B
$1.4B
—
AI Summary
Lucid builds high-end electric vehicles designed to compete with Tesla in the luxury segment. The company sells the Air sedan and recently launched the Gravity SUV through direct-to-consumer channels including online sales and retail locations. Lucid also develops proprietary EV powertrains, battery systems, and in-house software for its vehicles [Yahoo Finance].
Lucid Group designs and manufactures luxury electric vehicles including the Air sedan and Gravity SUV, competing in the premium EV market [Yahoo Finance]. The company is majority-owned by Saudi Arabia's Public Investment Fund (45.38% stake) and operates as a subsidiary of Ayar Third Investment Company [EODHD]. Despite advanced technology and strong revenue growth (+67.6% year-over-year), Lucid faces severe profitability challenges with negative gross margins and massive cash burn [Yahoo Finance].
Lucid is growing revenue rapidly but burning cash at an unsustainable rate with deeply negative margins across all profitability measures.
Recent News
3 Things You Have to Consider Before Even Entertaining Lucid
Yahoo Finance· 2026-05-20Lucid Price Prediction: 50% Upside, or Value Trap?
Yahoo Finance· 2026-05-18Lucid Diagnostics Q1 Earnings Call Highlights
Yahoo Finance· 2026-05-145 Insightful Analyst Questions From Lucid’s Q1 Earnings Call
Yahoo Finance· 2026-05-15Is Lucid Under $7 a Bargain or a Trap? Here's the Honest Answer.
Yahoo Finance· 2026-05-14Saudi fund PIF value declined by 7.3% in Q1
Seeking Alpha· 2026-05-15
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full Lucid Group Inc analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
Other companies you might find interesting
Same sector (Consumer Cyclical) or comparable health.